Author： Shantsila Eduard Watson Timothy Lip Gregory Y.H.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.24, Iss.10, 2006-01, pp. : 1035-1038
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
ATP III update targets high-risk patients, statins market to benefit?
Inpharma, Vol. 1, Iss. 1447, 2004-01 ,pp. :
Access to resources
Recommend
ATP III update targets high-risk patients, statins market to benefit?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 458, 2004-01 ,pp. :
On-treatment apolipoprotein levels: predictive benefit?
Inpharma, Vol. 1, Iss. 1271, 2001-01 ,pp. :
Can tumour response predict a survival benefit?
Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. :